Found: 45
Select item for more details and to access through your institution.
In situ hybridization to detect DNA amplification in extracellular vesicles.
- Published in:
- Journal of Extracellular Vesicles, 2022, v. 11, n. 9, p. 1, doi. 10.1002/jev2.12251
- By:
- Publication type:
- Article
miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs.
- Published in:
- Nucleic Acids Research, 2015, v. 43, n. 9, p. 5416, doi. 10.1093/nar/gku202
- By:
- Publication type:
- Article
miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs.
- Published in:
- Nucleic Acids Research, 2014, v. 42, n. 9, p. 5416
- By:
- Publication type:
- Article
Corrigendum: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.
- Published in:
- Nature Medicine, 2014, v. 20, n. 1, p. 103, doi. 10.1038/nm0114-103
- By:
- Publication type:
- Article
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.
- Published in:
- Nature Medicine, 2012, v. 18, n. 1, p. 74, doi. 10.1038/nm.2577
- By:
- Publication type:
- Article
The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 191, doi. 10.1111/bjh.19218
- By:
- Publication type:
- Article
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 2, p. 244, doi. 10.1111/bjh.19018
- By:
- Publication type:
- Article
In vitro anti‐lymphoma activity of the first‐in‐class pan‐NOTCH transcription inhibitor CB‐103.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 5, p. 669, doi. 10.1111/bjh.18576
- By:
- Publication type:
- Article
Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 595, doi. 10.1111/bjh.16118
- By:
- Publication type:
- Article
Late relapse in patients with diffuse large B‐cell lymphoma: impact of rituximab on their incidence and outcome.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 4, p. 478, doi. 10.1111/bjh.16106
- By:
- Publication type:
- Article
In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomas.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 149, doi. 10.1111/bjh.15727
- By:
- Publication type:
- Article
Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 6, p. 1022, doi. 10.1111/bjh.15212
- By:
- Publication type:
- Article
Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1–2 study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 453, doi. 10.1111/bjh.14817
- By:
- Publication type:
- Article
Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 936, doi. 10.1111/bjh.14803
- By:
- Publication type:
- Article
The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 3, p. 378, doi. 10.1111/bjh.13595
- By:
- Publication type:
- Article
Revised MALT‐IPI: A new predictive model that identifies high‐risk patients with extranodal marginal zone lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1529, doi. 10.1002/ajh.26715
- By:
- Publication type:
- Article
Gradual Rarefaction of Hematopoietic Precursors and Atrophy in a Depleted microRNA 29a, b and c Environment.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131981
- By:
- Publication type:
- Article
Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088525
- By:
- Publication type:
- Article
MIDClass: Microarray Data Classification by Association Rules and Gene Expression Intervals.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0069873
- By:
- Publication type:
- Article
Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055910
- By:
- Publication type:
- Article
Radiomics Analysis of [<sup>18</sup>F]-Fluorodeoxyglucose-Avid Thyroid Incidentalomas Improves Risk Stratification and Selection for Clinical Assessment.
- Published in:
- Thyroid, 2021, v. 31, n. 1, p. 88, doi. 10.1089/thy.2020.0224
- By:
- Publication type:
- Article
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study †.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1018, doi. 10.3390/cancers14041018
- By:
- Publication type:
- Article
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1912, doi. 10.3390/cancers12071912
- By:
- Publication type:
- Article
The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 775, doi. 10.3390/cancers11060775
- By:
- Publication type:
- Article
The Role of FLI1 in mRNA Splicing and rRNA Processing of Diffuse Large B Cell Lymphoma (DLBCL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S373, doi. 10.1016/j.clml.2017.07.212
- By:
- Publication type:
- Article
The BET Bromodomain Inhibitor (BETi) OTX015 (MK-8628) Upregulates miR-96-5p in Diffuse Large B-Cell Lymphomas (DLBCL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S105, doi. 10.1016/j.clml.2016.07.151
- By:
- Publication type:
- Article
The Genetics of Nodal Marginal Zone Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S102, doi. 10.1016/j.clml.2016.07.149
- By:
- Publication type:
- Article
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R‐CHOP14: A SAKK 38/07 trial post‐hoc analysis.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 11, doi. 10.1002/hon.2935
- By:
- Publication type:
- Article
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 715, doi. 10.1002/hon.2805
- By:
- Publication type:
- Article
Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.834075
- By:
- Publication type:
- Article
Correction to: cuRnet: an R package for graph traversing on GPU.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
cuRnet: an R package for graph traversing on GPU.
- Published in:
- BMC Bioinformatics, 2018, v. 19, n. 10, p. 221, doi. 10.1186/s12859-018-2310-3
- By:
- Publication type:
- Article
Exon–Intron Differential Analysis Reveals the Role of Competing Endogenous RNAs in Post-Transcriptional Regulation of Translation.
- Published in:
- Non-Coding RNA, 2021, v. 7, n. 2, p. 1, doi. 10.3390/ncrna7020026
- By:
- Publication type:
- Article
Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization.
- Published in:
- Non-Coding RNA, 2019, v. 5, n. 3, p. 1, doi. 10.3390/ncrna5030047
- By:
- Publication type:
- Article
Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.903536
- By:
- Publication type:
- Article
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02159-3
- By:
- Publication type:
- Article
Mutational landscape of canine B-cell lymphoma profiled at single nucleotide resolution by RNA-seq.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0215154
- By:
- Publication type:
- Article
miR-EdiTar: a database of predicted A-to-I edited miRNA target sites.
- Published in:
- Bioinformatics, 2012, v. 28, n. 23, p. 3166
- By:
- Publication type:
- Article
Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 764, doi. 10.1002/jha2.535
- By:
- Publication type:
- Article
DNA Copy Number Changes in Diffuse Large B Cell Lymphomas.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.584095
- By:
- Publication type:
- Article
KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
RNAdetector: a free user-friendly stand-alone and cloud-based system for RNA-Seq data analysis.
- Published in:
- BMC Bioinformatics, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12859-021-04211-7
- By:
- Publication type:
- Article